Your browser doesn't support javascript.
loading
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).
Int J Stroke ; 7(1): 74-80, 2012 Jan.
Article in En | MEDLINE | ID: mdl-22188854

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombolytic Therapy / Tissue Plasminogen Activator / Stroke / Fibrinolytic Agents Type of study: Clinical_trials / Guideline Limits: Female / Humans / Male / Middle aged Language: En Journal: Int J Stroke Year: 2012 Document type: Article Affiliation country: Australia Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombolytic Therapy / Tissue Plasminogen Activator / Stroke / Fibrinolytic Agents Type of study: Clinical_trials / Guideline Limits: Female / Humans / Male / Middle aged Language: En Journal: Int J Stroke Year: 2012 Document type: Article Affiliation country: Australia Country of publication: United States